In the present day, there is a great concern about the second deadliest disease, cancer. An enormous number of mortalities rate is increasing every year because of cancer despite a few inter-cessions accessible. Advancements in potency with fewer side effects make anticancer treatment a promising area of drug devel...
Mahesh Agasa Ramu, S. Gunturu, Somashekhar M. Metri et al.· Current Advances in Medicine· 0 citations
New findings on the design of small molecules that inhibit EGFR including pyrimidine‐5‐carbonitrile, thiazolyl‐pyrazolines, quinoxaline, quinazoline–sulfonamide hybrids, xanthine–chalcone conjugates, aminoquinolines, and pyridazine analogues are summarized.
Neelima Shrivastava, C. Ranjan· ChemistrySelect· 0 citations
The present study demonstrates that DHPM derivatives, specifically DHPM 22, may represent a promising lead for the development of new antioxidant derivatives, and further experimental studies are recommended to confirm their biological activities and therapeutic potential.
Chanda Ranjan, A. Mahesh, B. C. et al.· Current Computer - Aided Dru...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.